We are live on ! Find out more
Zurich Cantonal Bank

Zurich Cantonal Bank Portfolio holdings

AUM $46B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+16.89%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$16.4B
AUM Growth
+$2.26B
Cap. Flow
+$181M
Cap. Flow %
1.1%
Top 10 Hldgs %
25.12%
Holding
2,675
New
96
Increased
1,087
Reduced
489
Closed
66

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$34.7M
2
LOGI icon
Logitech
LOGI
+$31.9M
3
EWBC icon
East-West Bancorp
EWBC
+$25.3M
4
ALV icon
Autoliv
ALV
+$24.5M
5
MOS icon
The Mosaic Company
MOS
+$21.5M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$24.8M
2
JPM icon
JPMorgan Chase
JPM
+$17.9M
3
AAPL icon
Apple
AAPL
+$17.8M
4
PFE icon
Pfizer
PFE
+$15.1M
5
MDLZ icon
Mondelez International
MDLZ
+$14.9M

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Financials 15.13%
3 Healthcare 13.19%
4 Consumer Discretionary 12.43%
5 Communication Services 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPT icon
2176
Sprout Social
SPT
$605M
$93K ﹤0.01%
2,043
TBBK icon
2177
The Bancorp
TBBK
$2.84B
$93K ﹤0.01%
6,789
+3,192
+89% +$36.1K
ARR
2178
Armour Residential REIT
ARR
$2.37B
$92K ﹤0.01%
1,700
+739
+77% +$38K
BRKL
2179
DELISTED
Brookline Bancorp
BRKL
$92K ﹤0.01%
7,639
COLL icon
2180
Collegium Pharmaceutical
COLL
$867M
$92K ﹤0.01%
4,583
PRPL icon
2181
Purple Innovation
PRPL
$31.1M
$92K ﹤0.01%
+112
New +$81.6K
RBBN icon
2182
Ribbon Communications
RBBN
$358M
$92K ﹤0.01%
13,959
+10,205
+272% +$53.9K
YMAB
2183
DELISTED
Y-mAbs Therapeutics
YMAB
$92K ﹤0.01%
1,868
GTHX
2184
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$92K ﹤0.01%
5,118
+2,278
+80% +$34K
ARCT icon
2185
Arcturus Therapeutics
ARCT
$208M
$91K ﹤0.01%
2,099
+377
+22% +$25.5K
ATEX icon
2186
Anterix
ATEX
$1.84B
$91K ﹤0.01%
2,427
CLBK icon
2187
Columbia Financial
CLBK
$1.15B
$91K ﹤0.01%
5,823
-2,956
-34% -$40.9K
TGI
2188
DELISTED
Triumph Group
TGI
$91K ﹤0.01%
7,206
+2,928
+68% +$30.4K
ATNX
2189
DELISTED
Athenex, Inc. Common Stock
ATNX
$91K ﹤0.01%
412
+157
+62% +$38.6K
DCOM
2190
DELISTED
Dime Community Bancshares
DCOM
$91K ﹤0.01%
5,777
CARS icon
2191
Cars.com
CARS
$638M
$90K ﹤0.01%
7,960
+4,270
+116% +$42.8K
CXW icon
2192
CoreCivic
CXW
$3.35B
$90K ﹤0.01%
13,729
MX icon
2193
Magnachip Semiconductor
MX
$143M
$90K ﹤0.01%
6,648
WT icon
2194
WisdomTree
WT
$3.38B
$90K ﹤0.01%
16,741
+9,647
+136% +$41.5K
QUOT
2195
DELISTED
Quotient Technology Inc
QUOT
$90K ﹤0.01%
9,539
AGX icon
2196
Argan
AGX
$8.19B
$89K ﹤0.01%
1,999
AGYS icon
2197
Agilysys
AGYS
$3.01B
$89K ﹤0.01%
2,321
MYE icon
2198
Myers Industries
MYE
$1.22B
$89K ﹤0.01%
4,303
VVX icon
2199
V2X
VVX
$2.54B
$89K ﹤0.01%
1,783
TVRD
2200
Tvardi Therapeutics
TVRD
$22.4M
$89K ﹤0.01%
164

Similar funds

Zurich Cantonal Bank's Q4 2020 Portfolio in Review

As of Q4 2020, Zurich Cantonal Bank held 2,675 positions worth $16.4B, up 16% from $14.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Zurich Cantonal Bank's Q4 2020 filing shows 96 new, 1,087 increased, 489 reduced and 66 closed positions. Its largest new stake was 10x Genomics: 31,684 shares worth $4.49M. The largest sale was Danaher, an estimated $24.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Zurich Cantonal Bank's largest Q4 2020 buy was 10x Genomics: 31,684 shares worth $4.49M.
  • Zurich Cantonal Bank added most to UBS Group in Q4 2020, an estimated $34.7M increase.
  • Zurich Cantonal Bank's biggest Q4 2020 reduction was Danaher, cutting an estimated $24.8M.
  • Zurich Cantonal Bank fully exited E*Trade Financial Corporation in Q4 2020, selling an estimated $4.7M.
  • Zurich Cantonal Bank's ten largest holdings make up 25% of its $16.4B portfolio in Q4 2020.
  • Zurich Cantonal Bank opened 96 new positions and closed 66 in Q4 2020.
  • Zurich Cantonal Bank's portfolio value rose 16% quarter-over-quarter to $16.4B.

Based on Zurich Cantonal Bank's 13F filing for Q4 2020, filed 28 Jan 2021.